(Q37145284)

English

Use of erythropoiesis stimulating agents and intravenous iron for cancer and treatment-related anaemia: the need for predictors and indicators of effectiveness has not abated.

scientific article published on 22 April 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18430192%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

Europe PubMed Central

Use of erythropoiesis stimulating agents and intravenous iron for cancer and treatment-related anaemia: the need for predictors and indicators of effectiveness has not abated (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18430192%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18430192%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

author name string

Eirini Katodritou

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18430192%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Konstantinos Zervas

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18430192%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Evangelos Terpos

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18430192%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

language of work or name

0 references

publication date

22 April 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18430192%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18430192%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

142

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18430192%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18430192%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

3-10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18430192%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07163.X

21 January 2018

Hypersensitivity reactions and deaths associated with intravenous iron preparations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07163.X

21 January 2018

Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07163.X

21 January 2018

EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07163.X

21 January 2018

Mature erythrocyte parameters as new markers of functional iron deficiency in haemodialysis: sensitivity and specificity.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07163.X

21 January 2018

Reticulocyte cellular indices: a new approach in the diagnosis of anemias and monitoring of erythropoietic function

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07163.X

21 January 2018

Iron Deficiency and Erythropoiesis: New Diagnostic Approaches

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07163.X

21 January 2018

Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07163.X

21 January 2018

Erythropoiesis and iron

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07163.X

21 January 2018

Iron and the anaemia of chronic disease: a review and strategic recommendations.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07163.X

21 January 2018

Clinical utility of serum soluble transferrin receptor levels and comparison with bone marrow iron stores as an index for iron-deficient erythropoiesis in a heterogeneous group of patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07163.X

21 January 2018

Update on adverse drug events associated with parenteral iron

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07163.X

21 January 2018

The role of iron in infections with intracellular bacteria

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07163.X

21 January 2018

Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07163.X

21 January 2018

Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07163.X

21 January 2018

The safety of intravenous iron dextran in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07163.X

21 January 2018

Erythropoietin and iron-restricted erythropoiesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07163.X

21 January 2018

Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07163.X

21 January 2018

Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07163.X

21 January 2018

Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07163.X

21 January 2018

Iron overload and its association with cancer risk in humans: evidence for iron as a carcinogenic metal

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07163.X

21 January 2018

Considerations for optimal iron use for anemia due to chronic kidney disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07163.X

21 January 2018

Evaluation of hypochromic erythrocytes in combination with sTfR-F index for predicting response to r-HuEPO in anemic patients with multiple myeloma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07163.X

21 January 2018

Lack of functional erythropoietin receptors of cancer cell lines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07163.X

21 January 2018

Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07163.X

21 January 2018

Erythropoietin treatment of anemia associated with multiple myeloma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07163.X

21 January 2018

Detection of functional iron deficiency during erythropoietin treatment: a new approach

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07163.X

21 January 2018

Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07163.X

21 January 2018

Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07163.X

21 January 2018

Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07163.X

21 January 2018

Intravenous iron therapy: well-tolerated, yet not harmless

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07163.X

21 January 2018

Epoetin treatment of anemia associated with cancer therapy: a systematic review and meta-analysis of controlled clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07163.X

21 January 2018

Expression and function of erythropoietin receptors in tumors: implications for the use of erythropoiesis-stimulating agents in cancer patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07163.X

21 January 2018

Is stored iron safe?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07163.X

21 January 2018

Prolonged administration of erythropoietin increases erythroid response rate in myelodysplastic syndromes: a phase II trial in 281 patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07163.X

21 January 2018

The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07163.X

21 January 2018

Anemia of chronic disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07163.X

21 January 2018

Benefits and risks of iron therapy for chronic anaemias

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07163.X

21 January 2018

Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07163.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37145284&oldid=2123836717"